Open Access Open Access  Restricted Access Subscription Access

A Review of Cardiac Biomarkers

Muralinath E., Sony Sharlet E., Radhakrishna P.

Abstract


Endogenous chemicals released into the bloodstream when the heart is damaged or under stress are known as cardiac biomarkers. Acute coronary syndrome, a potentially fatal condition characterized by the abrupt onset of persistent pain in the chest, one or both arms, shoulders, abdomen, or jaw, as well as shortness of breath, nausea, sweating, and dizziness, can be diagnosed, risk-stratified, and treated with the help of these biomarker measurements.


Full Text:

PDF

References


Jacob, R., & Khan, M. (2018). Cardiac biomarkers: What is and what can be. Indian Journal of Cardiovascular Disease in Women WINCARS, 3(4), 240–244.

Collinson, P. O. (2009). Cardiac markers. British Journal of Hospital Medicine, 70(6), M84–M87.

Plebani, M., & Zaninotto, M. (1999). Cardiac markers: Present and future. International Journal of Clinical Laboratory Research, 29(2), 56–63.

Tiwari, R. P., Jain, A., Khan, Z., Kohli, V., Bharmal, R. N., Kartikeyan, S., & Bisen, P. S. (2012). Cardiac troponins I and T: Molecular markers for early diagnosis, prognosis, and accurate triaging of patients with acute myocardial infarction. Molecular Diagnosis & Therapy, 16(6), 371–381.

Singh, V., Martinezclark, P., Pascual, M., Shaw, E. S., & O'Neill, W. W. (2010). Cardiac biomarkers—the old and the new: A review. Coronary Artery Disease, 21(4), 244–256.

Cemin, R., & Daves, M. (2015). Pre-analytic variability in cardiovascular biomarker testing. Journal of Thoracic Disease, 7(10), E395–E401.

Lazar, D. R., Lazar, F. L., Homorodean, C., Cainap, C., Focsan, M., Cainap, S., & Olinic, D. M. (2022). High-sensitivity troponin: A review on characteristics, assessment, and clinical implications. Disease Markers, 2022, Article 9713326.

Dominici, R., Infusino, I., Valente, C., Moraschinelli, I., & Franzini, C. (2004). Plasma or serum samples: Measurements of cardiac troponin T and of other analytes compared. Clinical Chemistry and Laboratory Medicine, 42(8), 945–951.

Penttilä, I., Penttilä, K., & Rantanen, T. (2000). Laboratory diagnosis of patients with acute chest pain. Clinical Chemistry and Laboratory Medicine, 38(3), 187–197.

Hijazi, Z., Wallentin, L., Siegbahn, A., Andersson, U., Alexander, J. H., Atar, D., Gersh, B. J., Hanna, M., Harjola, V. P., Horowitz, J. D., Husted, S., Hylek, E. M., Lopes, R. D., McMurray, J. J., & Granger, C. B. (2014). High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. Journal of the American College of Cardiology, 63(1), 52–61.

Lafrenière, M. A., Tandon, V., Ainsworth, C., Nouri, [initials unclear], Mondoux, S. E., Worster, A., & Kavsak, P. A. (2023). Storage conditions, sample integrity, interferences, and a decision tool for investigating unusual high-sensitivity cardiac troponin results. Clinical Biochemistry, 115, 67–76.

Canovi, S., Campioli, D., & Marcheselli, L. (2015). Specimen recentrifugation and elevated troponin I levels. Laboratory Medicine, 46(1), 47–50.

Bowen, R. A., & Remaley, A. T. (2014). Interferences from blood collection tube components on clinical chemistry assays. Biochemia Medica, 24(1), 31–44.

Giavarina, D., & Lippi, G. (2017). Blood venous sample collection: Recommendations overview and a checklist to improve quality. Clinical Biochemistry, 50(10–11), 568–573.

Šimundić, A. M., Baird, G., Cadamuro, J., Costelloe, S. J., & Lippi, G. (2020). Managing hemolyzed samples in clinical laboratories. Critical Reviews in Clinical Laboratory Sciences, 57(1), 1–21.

Bhargava, S., Singla, P., Manocha, A., Kankra, M., Sharma, A., Ahirwar, A., Ralhan, R., Thapliyal, U., & Mehra, P. (2020). The hemolyzed sample: To analyse or not to analyse. Indian Journal of Clinical Biochemistry, 35(2), 232–238.

Wang, Y. H., Sun, X. F., Xu, C. X., Sun, F. Q., Wang, R. R., Bian, X. K., Wang, Z. Z., & Wu, Q. (2025). Preparation of recombinant myoglobin and investigation of the liquid antigen stability for quality control materials. Practical Laboratory Medicine, 44, Article e00456.

Sallach, S. M., Nowak, R., Hudson, M. P., Tokarski, G., Khoury, N., Tomlanovich, M. C., Jacobsen, G., de Lemos, J. A., & McCord, J. (2004). A change in serum myoglobin to detect acute myocardial infarction in patients with normal troponin I levels. The American Journal of Cardiology, 94(7), 864–867.

Srinivas, V. S., Cannon, C. P., Gibson, C. M., Antman, E. M., Greenberg, M. A., Tanasijevic, M. J., Murphy, S., de Lemos, J. A., Sokol, S., Braunwald, E., & Mueller, H. S. (2001). Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: A Thrombolysis in Myocardial Infarction 10B substudy. American Heart Journal, 142(1), 29–36.

Maalouf, R., & Bailey, S. (2016). A review on B-type natriuretic peptide monitoring: Assays and biosensors. Heart Failure Reviews, 21(5), 567–578.


Refbacks

  • There are currently no refbacks.